Related Experiment Video
Updated: Jun 3, 2026
09:25
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Airway inflammation and hypersensitivity induced by chronic smoking
Yu Ru Kou1, Kevin Kwong, Lu-Yuan Lee
1Institute of Physiology, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan, ROC.
Respiratory Physiology & Neurobiology
|March 15, 2011
Summary
Cigarette smoking causes airway inflammation, leading to airway hypersensitivity. This study identifies key signaling pathways and mechanisms contributing to this condition in smokers.
Area of Science:
- Respiratory Medicine
- Cellular Signaling
- Toxicology
Background:
- Airway hypersensitivity is a key feature of airway inflammatory diseases.
- Chronic airway inflammation, often caused by cigarette smoking, is linked to airway hyperresponsiveness.
- The precise mechanisms underlying this hypersensitivity are not fully understood.
Purpose of the Study:
- To investigate the mechanisms of airway hypersensitivity induced by chronic airway inflammation, using cigarette smoking as a model.
- To identify key cellular signaling pathways and mediators involved in smoking-induced airway inflammation and hyperresponsiveness.
Main Methods:
- Utilized cigarette smoking as an experimental model for chronic airway inflammation.
- Investigated the role of vagal bronchopulmonary sensory nerve excitability and tachykinin synthesis.
- Examined the involvement of inflammatory mediators, redox-sensitive signaling, and transcription factors.
Main Results:
- Chronic inflammation from smoking enhances airway sensory nerve excitability.
- Increased tachykinin synthesis in sensory nerves contributes to airway hyperresponsiveness.
- Inflammatory mediators like prostanoids and reactive oxygen species sensitize and stimulate airway sensory nerves.
Conclusions:
- Cigarette smoking induces airway inflammation and hypersensitivity through specific cellular signaling pathways.
- Enhanced nerve excitability and mediator synthesis are critical mechanisms in smoking-related airway hyperresponsiveness.
- Understanding these pathways offers insights into managing airway inflammatory diseases.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.